32 results
8-K
EX-99.1
ALGS
Aligos Therapeutics Inc
3 Aug 23
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2023 Financial Results
4:05pm
facility expenses due to the right-of-use asset impairment, largely offset by a decrease in third party expenses from the reduced manufacturing of drug … period is primarily attributable to an increase in legal and related costs offset by a decrease in facility expenses. Total G&A stock-based
8-K
EX-99.1
ALGS
Aligos Therapeutics Inc
12 Mar 24
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
4:06pm
and ASO programs in 2022, partially offset by increases in our ongoing activities and related expenditures associated with our CAM clinical trial … and patent attorney costs, partially offset by a decrease in facility expenses. Total G&A stock-based compensation expense incurred for the year ended
DEFA14A
ALGS
Aligos Therapeutics Inc
27 Apr 21
Additional proxy soliciting materials
4:19pm
materials.
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee
8-K
EX-99.1
ALGS
Aligos Therapeutics Inc
4 May 23
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2023 Financial Results
4:05pm
period is primarily attributable to an increase in legal and related costs offset by a decrease in facility expenses. Total G&A stock-based
8-K
EX-99.1
ALGS
Aligos Therapeutics Inc
4 Aug 22
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2022 Financial Results
4:06pm
programs offset by our expenditures related to the ongoing development and manufacturing activities associated with our CAM and NASH clinical program
8-K
EX-99.1
6sipox vwx
2 Nov 23
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results
4:05pm
8-K
EX-99.1
ngawy
4 May 22
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2022 Financial Results
4:06pm
8-K
EX-99.1
zdglv 16p
7 May 24
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
4:05pm